Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 16492, 4 pages
http://dx.doi.org/10.1155/MI/2006/16492
Short Communication

Serum IL-18 Is Increased at Early Postburn Period in Moderately Burned Patients

1Department of Plastic Surgery, School of Medicine, Sutcu Imam University, Kahramanmaras 46100, Turkey
2Department of Microbiology and Immunology, School of Medicine, Sutcu Imam University, Kahramanmaras 46100, Turkey

Received 24 June 2005; Accepted 15 November 2005

Copyright © 2006 Y. Kenan Coban and Murat Aral. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M Ueyama, I Maruyama, M Osame, and Y Sawada, “Marked increase in plasma interleukin-6 in burn patients,” The Journal of Laboratory and Clinical Medicine, vol. 120, no. 5, pp. 693–698, 1992. View at Google Scholar
  2. S Endo, K Inada, Y Yamada et al., “Plasma tumour necrosis factor-α (TNF-α) levels in patients with burns,” Burns, vol. 19, no. 2, pp. 124–127, 1993. View at Publisher · View at Google Scholar
  3. A L Dugan, W B Malarkey, S Schwemberger, E C Jauch, C K Ogle, and N D Horseman, “Serum levels of prolactin, growth hormone, and cortisol in burn patients: correlations with severity of burn, serum cytokine levels, and fatality,” Journal of Burn Care & Rehabilitation, vol. 25, no. 3, pp. 306–313, 2004. View at Google Scholar
  4. J P de Bandt, S Chollet-Martin, A Hernvann et al., “Cytokine response to burn injury: relationship with protein metabolism,” The Journal of Trauma, vol. 36, no. 5, pp. 624–628, 1994. View at Google Scholar
  5. F L Yeh, W L Lin, and H D Shen, “Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients,” Burns, vol. 26, no. 5, pp. 454–459, 2000. View at Publisher · View at Google Scholar
  6. F L Yeh, W L Lin, H D Shen, and R H Fang, “Changes in circulating levels of interleukin 6 in burned patients,” Burns, vol. 25, no. 2, pp. 131–136, 1999. View at Publisher · View at Google Scholar
  7. F L Yeh, W L Lin, H D Shen, and R H Fang, “Changes in serum tumour necrosis factor-α in burned patients,” Burns, vol. 23, no. 1, pp. 6–10, 1997. View at Publisher · View at Google Scholar
  8. D Takeuchi, H Yoshidome, A Kato et al., “Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice,” Hepatology, vol. 39, no. 3, pp. 699–710, 2004. View at Publisher · View at Google Scholar
  9. F N Lauw, J Branger, S Florquin et al., “IL-18 improves the early antimicrobial host response to pneumococcal pneumonia,” The Journal of Immunology, vol. 168, no. 1, pp. 372–378, 2002. View at Google Scholar
  10. “American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Critical Care Medicine, vol. 20, no. 6, pp. 864–874, 1992.
  11. K Nakanishi, T Yoshimoto, H Tsutsui, and H Okamura, “Interleukin-18 regulates both Th1 and Th2 responses,” Annual Review of Immunology, vol. 19, pp. 423–474, 2001. View at Publisher · View at Google Scholar
  12. K Nakanishi, T Yoshimoto, H Tsutsui, and H Okamura, “Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu,” Cytokine & Growth Factor Reviews, vol. 12, no. 1, pp. 53–72, 2001. View at Google Scholar
  13. H Okamura, H Tsutsi, T Komatsu et al., “Cloning of a new cytokine that induces IFN-γ production by T cells,” Nature, vol. 378, no. 6552, pp. 88–91, 1995. View at Publisher · View at Google Scholar
  14. S Ushio, M Namba, T Okura et al., “Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein,” The Journal of Immunology, vol. 156, no. 11, pp. 4274–4279, 1996. View at Google Scholar
  15. A Billiau, “Interferon-gamma: biology and role in pathogenesis,” Advances in Immunology, vol. 62, pp. 61–130, 1996. View at Google Scholar
  16. W-D Döcke, F Randow, U Syrbe et al., “Monocyte deactivation in septic patients: restoration by IFN-γ treatment,” Nature Medicine, vol. 3, no. 6, pp. 678–681, 1997. View at Google Scholar
  17. B Conti, J W Jahng, C Tinti, J H Son, and T H Joh, “Induction of interferon-γ inducing factor in the adrenal cortex,” The Journal of Biological Chemistry, vol. 272, no. 4, pp. 2035–2037, 1997. View at Publisher · View at Google Scholar
  18. T Suda, T Takahashi, P Golstein, and S Nagata, “Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family,” Cell, vol. 75, no. 6, pp. 1169–1178, 1993. View at Publisher · View at Google Scholar
  19. A McKay, M Komai-Koma, K J MacLeod et al., “Interleukin-18 levels in induced sputum are reduced in asthmatic and normal smokers,” Clinical & Experimental Allergy, vol. 34, no. 6, pp. 904–910, 2004. View at Google Scholar
  20. F Giugliano, K Esposito, C Di Palo et al., “Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men,” Journal of Endocrinological Investigation, vol. 27, no. 7, pp. 665–669, 2004. View at Google Scholar
  21. H M Wang, W F Cao, Y Z Peng, G X Xiao, and X Y Yang, “Changes in plasma levels of LPS, TNF-α and IL-6 in burn patients with severe infection treated with Imipenem or Cefoperazone,” Zhonghua Shao Shang Za Zhi, vol. 20, no. 2, pp. 95–97, 2004 (Chinese). View at Google Scholar
  22. M Kinoshita, S Seki, S Ono, N Shinomiya, and H Hiraide, “Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice,” Annals of Surgery, vol. 240, no. 2, pp. 313–320, 2004. View at Publisher · View at Google Scholar
  23. M G Netea, G Fantuzzi, B J Kullberg et al., “Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia,” The Journal of Immunology, vol. 164, no. 5, pp. 2644–2649, 2000. View at Google Scholar
  24. B Liu, I Mori, M J Hossain, L Dong, K Takeda, and Y Kimura, “Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity,” Journal of General Virology, vol. 85, no. pt 2, pp. 423–428, 2004. View at Publisher · View at Google Scholar
  25. K Kohno, J Kataoka, T Ohtsuki et al., “IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12,” The Journal of Immunology, vol. 158, no. 4, pp. 1541–1550, 1997. View at Google Scholar